11 – 20 of 769
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Synergy of triazolyl substituents at C1 and C3 of galactose for high-affinity and selective galectin-4C inhibition
2025) In RSC Chemical Biology(
- Contribution to journal › Article
-
Mark
Clinical and molecular aspects of urinary tract infection in infants
2025) In Lund University, Faculty of Medicine Doctoral Dissertation(
- Thesis › Doctoral thesis (compilation)
-
Mark
Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction
(
- Contribution to journal › Article
- 2024
-
Mark
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver
(
- Contribution to journal › Article
-
Mark
Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils
(
- Contribution to journal › Article
-
Mark
Adherence to the Swedish paediatric guidelines for urinary tract infections
2024) In Acta Paediatrica, International Journal of Paediatrics(
- Contribution to journal › Article
-
Mark
Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of Cancer
(
- Contribution to journal › Article
-
Mark
Clinical and molecular response to alpha1-oleate treatment in patients with bladder cancer
(
- Contribution to journal › Article
-
Mark
Sulfonamide-derivatized galactosides selectively target an unexplored binding site in the galectin-9N-terminal domain
(
- Contribution to journal › Article
-
Mark
Infant urinary tract infection in Sweden — A national study of current diagnostic procedures, imaging and treatment
(
- Contribution to journal › Article